IMCD N.V. (FRA:INX)

Intra-Cellular Therapies Statistics

Total Valuation

IMCD N.V. has a market cap or net worth of EUR 5.57 billion. The enterprise value is 7.12 billion.

Market Cap	5.57B
Enterprise Value	7.12B

Important Dates

The last earnings date was Wednesday, July 30, 2025.

Earnings Date	Jul 30, 2025
Ex-Dividend Date	Apr 29, 2025

Share Statistics

Current Share Class	59.03M
Shares Outstanding	n/a
Shares Change (YoY)	+2.45%
Shares Change (QoQ)	+2.85%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	55.47M

Valuation Ratios

The trailing PE ratio is 20.89 and the forward PE ratio is 15.20.

PE Ratio	20.89
Forward PE	15.20
PS Ratio	1.15
PB Ratio	2.82
P/TBV Ratio	n/a
P/FCF Ratio	24.53
P/OCF Ratio	23.23
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.31, with an EV/FCF ratio of 31.33.

EV / Earnings	26.68
EV / Sales	1.47
EV / EBITDA	12.31
EV / EBIT	16.24
EV / FCF	31.33

Financial Position

The company has a current ratio of 1.75, with a Debt / Equity ratio of 0.88.

Current Ratio	1.75
Quick Ratio	1.04
Debt / Equity	0.88
Debt / EBITDA	3.00
Debt / FCF	7.63
Interest Coverage	6.35

Financial Efficiency

Return on equity (ROE) is 14.31% and return on invested capital (ROIC) is 7.53%.

Return on Equity (ROE)	14.31%
Return on Assets (ROA)	6.01%
Return on Invested Capital (ROIC)	7.53%
Return on Capital Employed (ROCE)	12.30%
Revenue Per Employee	917,045
Profits Per Employee	50,539
Employee Count	5,126
Asset Turnover	1.06
Inventory Turnover	5.13

Taxes

In the past 12 months, IMCD N.V. has paid 94.09 million in taxes.

Income Tax	94.09M
Effective Tax Rate	26.08%

Stock Price Statistics

The stock price has decreased by -15.77% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-15.77%
50-Day Moving Average	113.20
200-Day Moving Average	130.19
Relative Strength Index (RSI)	27.56
Average Volume (20 Days)	97

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, IMCD N.V. had revenue of EUR 4.84 billion and earned 266.69 million in profits. Earnings per share was 4.57.

Revenue	4.84B
Gross Profit	1.25B
Operating Income	438.05M
Pretax Income	360.73M
Net Income	266.69M
EBITDA	545.87M
EBIT	438.05M
Earnings Per Share (EPS)	4.57

Balance Sheet

The company has 190.43 million in cash and 1.73 billion in debt, giving a net cash position of -1.54 billion.

Cash & Cash Equivalents	190.43M
Total Debt	1.73B
Net Cash	-1.54B
Net Cash Per Share	n/a
Equity (Book Value)	1.98B
Book Value Per Share	33.46
Working Capital	797.04M

Cash Flow

In the last 12 months, operating cash flow was 239.85 million and capital expenditures -12.76 million, giving a free cash flow of 227.10 million.

Operating Cash Flow	239.85M
Capital Expenditures	-12.76M
Free Cash Flow	227.10M
FCF Per Share	n/a

Margins

Gross margin is 25.89%, with operating and profit margins of 9.05% and 5.51%.

Gross Margin	25.89%
Operating Margin	9.05%
Pretax Margin	7.45%
Profit Margin	5.51%
EBITDA Margin	11.28%
EBIT Margin	9.05%
FCF Margin	4.69%

Dividends & Yields

This stock pays an annual dividend of 2.15, which amounts to a dividend yield of 1.91%.

Dividend Per Share	2.15
Dividend Yield	1.91%
Dividend Growth (YoY)	-4.02%
Years of Dividend Growth	n/a
Payout Ratio	47.63%
Buyback Yield	-2.45%
Shareholder Yield	-0.54%
Earnings Yield	4.79%
FCF Yield	4.08%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

IMCD N.V. has an Altman Z-Score of 3.65 and a Piotroski F-Score of 5.

Altman Z-Score	3.65
Piotroski F-Score	5